Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Vimian Group AB ( (SE:VIMIAN) ).
Vimian Group AB has announced the issuance and repurchase of various classes of shares as part of its long-term incentive program (LTIP 2025). This strategic move, authorized during an Extraordinary General Meeting, aims to enhance employee engagement and align interests with shareholders, potentially strengthening Vimian’s market position and operational focus.
The most recent analyst rating on (SE:VIMIAN) stock is a Hold with a SEK35.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.
More about Vimian Group AB
Vimian is a global animal health company headquartered in Stockholm, Sweden, focusing on Specialty Pharma, MedTech, Veterinary Services, and Diagnostics. It serves over 17,000 veterinary clinics and laboratories across more than 80 markets, with a workforce of 1,200 employees and annual revenues of approximately EUR 375 million.
YTD Price Performance: -20.20%
Average Trading Volume: 636,205
Technical Sentiment Signal: Sell
Current Market Cap: SEK16.7B
Find detailed analytics on VIMIAN stock on TipRanks’ Stock Analysis page.